Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 20, 2024, titled "USFDA concludes inspection at Solara s Visakhapatnam Facility with Zero 483 inspectional observations.".
Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated May 20, 2024, titled "USFDA concludes inspection at Solara s Visakhapatnam Facility with Zero 483 inspectional observations.".